Muscular effects of statins in the elderly female: a review

被引:63
作者
Bhardwaj, Shilpa [1 ,2 ]
Selvarajah, Shalini
Schneider, Eric B. [3 ]
机构
[1] Griffin Hosp, Derby, CT USA
[2] Yale Univ, New Haven, CT USA
[3] Johns Hopkins Sch Med, Dept Surg, Ctr Surg Trials & Outcomes Res, Baltimore, MD 21287 USA
关键词
statins; older adults; elderly; females; epidemiology; COA REDUCTASE INHIBITORS; CHOLESTEROL-LOWERING TREATMENT; ADVERSE DRUG-REACTIONS; INDUCED MYOPATHY; GENDER-DIFFERENCES; SKELETAL-MUSCLE; SEX-DIFFERENCES; SAFETY; THERAPY; RISK;
D O I
10.2147/CIA.S29686
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Statins have demonstrated substantial benefits in supporting cardiovascular health. Older individuals are more likely to experience the well-known muscle-related side effects of statins compared with younger individuals. Elderly females may be especially vulnerable to statin-related muscle disorder. This review will collate and discuss statin-related muscular effects, examine their molecular and genetic basis, and how these apply specifically to elderly women. Developing strategies to reduce the incidence of statin-induced myopathy in older adult women could contribute to a significant reduction in the overall incidence of statin-induced muscle disorder in this vulnerable group of patients. Reducing statin-related muscle disorder would likely improve overall patient compliance, thereby leading to an increase in improved short- and long-term outcomes associated with appropriate use of statins.
引用
收藏
页码:47 / 59
页数:13
相关论文
共 87 条
[1]   Management of Hyperlipidemia in Older Adults [J].
Alexander, Karen P. ;
Blazing, Michael A. ;
Rosenson, Robert S. ;
Hazard, Elisabeth ;
Aronow, Wilbert S. ;
Smith, Sidney C. ;
Ohman, E. Magnus .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 14 (01) :49-58
[2]   Gender differences in pharmacological response [J].
Anderson, Gail D. .
EPILEPSY IN WOMEN: THE SCIENTIFIC BASIS FOR CLINICAL MANAGEMENT, 2008, 83 :1-10
[3]  
[Anonymous], 2011, Health, United States, 2010: With Special feature on death and dying
[4]   Statin-induced myopathy: The two faces of Janus [J].
Arora, Rohit ;
Liebo, Max ;
Maldonado, Frank .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2006, 11 (02) :105-112
[5]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[6]   Molecular clues into the pathogenesis of statin-mediated muscle toxicity [J].
Baker, SK .
MUSCLE & NERVE, 2005, 31 (05) :572-580
[7]   Risk for myopathy with statin therapy in high-risk patients [J].
Ballantyne, CM ;
Corsini, A ;
Davidson, MH ;
Holdaas, H ;
Jacobson, TA ;
Leitersdorf, E ;
März, W ;
Reckless, JPD ;
Stein, EA .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (05) :553-564
[8]   Statin safety: An overview and assessment of the data-2005 [J].
Bays, H .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (8A) :6C-26C
[9]   Adverse Effects of Statins - Mechanisms and Consequences [J].
Beltowski, Jerzy ;
Wojcicka, Grazyna ;
Jamroz-Wisniewska, Anna .
CURRENT DRUG SAFETY, 2009, 4 (03) :209-228
[10]   Statin therapy for the octogenarian? [J].
Blom, D. J. .
JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2012, 17 (01) :37-42